A medical technologist and engineer, Thomas Strilko has over two decades’ experience in his field. Today, Thomas Strilko serves as the vice president of sales at Xifin, Inc., a healthcare information-technology company revolutionizing healthcare diagnostics across North America.
In March 2018, Xifin announced it was joining the American Society of Clinical Pathology’s (ASCP) global initiative “Partners to Cancer Diagnosis and Treatment in Africa.” The initiative provides patients in disadvantaged areas in sub-Saharan Africa quality cancer diagnostics to facilitate effective treatment.
In that part of the world, 650,000 new cancer diagnoses are made annually. The disease has a very high mortality rate because of inadequate screening technologies, laboratories, and pathologists. A situation which prevent timely diagnosis. By providing cloud-based telepathology, ASCP’s global initiative will improve cancer diagnosis and overall treatment outcomes in the region.
Xifin’s participation in the initiative means its revolutionary LIS Anywhere technology will be used to perform sample tracking and reporting in local communities in Africa. It will also be used to support case reviews and consultations with pathologists based in the United States.
